Kim CJ, Kim NH, Song KH, Choe PG, Kim ES, Park SW, et al. Differentiating rapid- and slow-growing mycobacteria by difference in time to growth detection in liquid media. Diagn Microbiol Infect Dis. 2013;75(1):73–6.

PubMed  Google Scholar 

Sharma SK, Upadhyay V. Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases. Indian J Med Res. 2020;152(3):185–226.

CAS  PubMed  PubMed Central  Google Scholar 

Chan CH, Ho AK, Chan RC, Cheung H, Cheng AF. Mycobacteria as a cause of infective exacerbation in bronchiectasis. Postgrad Med J. 1992;68(805):896–9.

CAS  PubMed  PubMed Central  Google Scholar 

Reich JM, Johnson RE. Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. Lady Windermere Syndrome Chest. 1992;101(6):1605–9.

CAS  PubMed  Google Scholar 

Zhou Y, Mu W, Zhang J, Wen SW, Pakhale S. Global prevalence of non-tuberculous mycobacteria in adults with non-cystic fibrosis bronchiectasis 2006–2021: a systematic review and meta-analysis. BMJ Open. 2022;12(8): e055672.

PubMed  PubMed Central  Google Scholar 

Haworth CS, Banks J, Capstick T, Fisher AJ, Gorsuch T, Laurenson IF, et al. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax. 2017;72(Suppl 2):ii1-64.

PubMed  Google Scholar 

Braeckel EV, Bosteels C. Growing from common ground: nontuberculous mycobacteria and bronchiectasis. Eur Respiratory Rev. 2024;33(173)

Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416.

CAS  PubMed  Google Scholar 

Aono Y, Hozumi H, Kono M, Hashimoto D, Nakamura H, Yokomura K, et al. Prognostic significance of radiological pleuroparenchymal fibroelastosis in Mycobacterium avium complex lung disease: a multicentre retrospective cohort study. Thorax. 2023;78(8):825–34.

PubMed  Google Scholar 

Chalmers JD, Aksamit T, Carvalho ACC, Rendon A, Franco I. Non-tuberculous mycobacterial pulmonary infections. Pulmonology. 2018;24(2):120–31.

Google Scholar 

Griffith DE, Aksamit TR. Understanding nontuberculous mycobacterial lung disease: it’s been a long time coming. F1000Res. 2016;5:2797.

PubMed  PubMed Central  Google Scholar 

Lake MA, Ambrose LR, Lipman MCI, Lowe DM. ‘”Why me, why now?” Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection. BMC Med. 2016;14(1):54.

PubMed  PubMed Central  Google Scholar 

Winthrop KL, Chang E, Yamashita S, Iademarco MF, LoBue PA. Nontuberculous Mycobacteria Infections and Anti–Tumor Necrosis Factor-α Therapy - Volume 15, Number 10—October 2009 - Emerging Infectious Diseases journal - CDC

Andréjak C, Nielsen R, Thomsen VØ, Duhaut P, Sørensen HT, Thomsen RW. Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis. Thorax. 2013;68(3):256–62.

PubMed  Google Scholar 

Markle JG, Martĺnez-Barricarte R, Ma CS, Deenick EK, Ramírez-Alejo N, Mele F, et al. Human IFN-γ immunity to mycobacteria is governed by both IL-12 and IL-23. Sci Immunol. 2018;3(30):eaau6759.

PubMed  PubMed Central  Google Scholar 

DeFlorio-Barker S, Egorov A, Smith GS, Murphy MS, Stout JE, Ghio AJ, et al. Environmental risk factors associated with pulmonary isolation of nontuberculous mycobacteria, a population-based study in the southeastern United States. Sci Total Environ. 2021;1(763):144552.

Google Scholar 

Kim RD, Greenberg DE, Ehrmantraut ME, Guide SV, Ding L, Shea Y, et al. Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med. 2008;178(10):1066–74.

CAS  PubMed  PubMed Central  Google Scholar 

Loebinger MR, Quint JK, van der Laan R, Obradovic M, Chawla R, Kishore A, et al. Risk Factors for Nontuberculous Mycobacterial Pulmonary Disease: A Systematic Literature Review and Meta-Analysis. Chest. 2023;164(5):1115–24.

PubMed  Google Scholar 

Grasemann H, Ratjen F. Cystic Fibrosis. N Engl J Med. 2023;389(18):1693–707.

CAS  PubMed  Google Scholar 

Szymanski EP, Leung JM, Fowler CJ, Haney C, Hsu AP, Chen F, et al. Pulmonary Nontuberculous Mycobacterial Infection. A Multisystem, Multigenic Disease. Am J Respir Crit Care Med. 2015;192(5):618–28.

CAS  PubMed  PubMed Central  Google Scholar 

Chen S, Zhong J, Yang Q, Song X, Zhang L, Ruan G, et al. Comparative analysis of non-tuberculous mycobacterial lung disease and lung colonization: a case-control study. BMC Infect Dis. 2024;24(1):1159.

CAS  PubMed  PubMed Central  Google Scholar 

Wobma H, Chang AK, Jin Z, Baker C, Garvin J, George D, et al. Low CD4 count may be a risk factor for non-tuberculous mycobacteria infection in pediatric hematopoietic cell transplant recipients. Pediatr Transplant. 2021;25(4): e13994.

CAS  PubMed  Google Scholar 

Garcia B, Wilmskoetter J, Grady A, Mingora C, Dorman S, Flume P. Chest Computed Tomography Features of Nontuberculous Mycobacterial Pulmonary Disease Versus Asymptomatic Colonization: A Cross-sectional Cohort Study. J Thorac Imaging. 2022;37(3):140.

PubMed  Google Scholar 

Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ, Andrejak C, et al. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline. Eur Respir J. 2020;56(1):2000535.

PubMed  PubMed Central  Google Scholar 

Lee MR, Yang CY, Shu CC, Lin CK, Wen YF, Lee SW, et al. Factors associated with subsequent nontuberculous mycobacterial lung disease in patients with a single sputum isolate on initial examination. Clin Microbiol Infect. 2015;21(3):250.e1-7.

PubMed  Google Scholar 

van Ingen J, Bendien SA, de Lange WCM, Hoefsloot W, Dekhuijzen PNR, Boeree MJ, et al. Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region. The Netherlands Thorax. 2009;64(6):502–6.

PubMed  Google Scholar 

Lee G, Lee KS, Moon JW, Koh WJ, Jeong BH, Jeong YJ, et al. Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans. Ann Am Thorac Soc. 2013;10(4):299–306.

PubMed  Google Scholar 

Kuroishi S, Nakamura Y, Hayakawa H, Shirai M, Nakano Y, Yasuda K, et al. Mycobacterium avium complex disease: prognostic implication of high-resolution computed tomography findings. Eur Respir J. 2008;32(1):147–52.

CAS  PubMed  Google Scholar 

Lam PK, Griffith DE, Aksamit TR, Ruoss SJ, Garay SM, Daley CL, et al. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2006;173(11):1283–9.

CAS  PubMed  Google Scholar 

Shu CC, Lee CH, Hsu CL, Wang JT, Wang JY, Yu CJ, et al. Clinical Characteristics and Prognosis of Nontuberculous Mycobacterial Lung Disease with Different Radiographic Patterns. Lung. 2011;189(6):467–74.

PubMed  Google Scholar 

Takeda K, Imamura Y, Takazono T, Yoshida M, Ide S, Hirano K, et al. The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients coinfected with nontuberculous mycobacteria. Med Mycol. 2016;54(2):120–7.

PubMed  Google Scholar 

Hayashi M, Takayanagi N, Kanauchi T, Miyahara Y, Yanagisawa T, Sugita Y. Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2012;185(5):575–83.

CAS  PubMed  Google Scholar 

Jenkins PA, Campbell IA, Banks J, Gelder CM, Prescott RJ, Smith AP. Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy. Thorax. 2008;63(7):627–34.

CAS  PubMed  Google Scholar 

Research Committee of the British Thoracic Society. First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol. Thorax. 2001;56(3):167–72.

Google Scholar 

Lyu J, Jang HJ, Song JW, Choi CM, Oh YM, Lee SD, et al. Outcomes in patients with Mycobacterium abscessus pulmonary disease treated with long-term injectable drugs. Respir Med. 2011;105(5):781–7.

PubMed  Google Scholar 

Harada T, Akiyama Y, Kurashima A, Nagai H, Tsuyuguchi K, Fujii T, et al. Clinical and microbiological differences between Mycobacterium abscessus and Mycobacterium massiliense lung diseases. J Clin Microbiol. 2012;50(11):3556–61.

CAS  PubMed  PubMed Central  Google Scholar 

Kim SY, Lee ST, Jeong BH, Jeon K, Kim JW, Shin SJ, et al. Clinical significance of mycobacterial genotyping in Mycobacterium avium lung disease in Korea. Int J Tuberc Lung Dis. 2012;16(10):1393–9.

PubMed  Google Scholar 

Koh WJ, Jeong BH, Jeon K, Lee NY, Lee KS, Woo SY, et al. Clinical significance of the differentiation between Mycobacterium avium and Mycobacterium intracellulare in M avium complex lung disease. Chest. 2012;142(6):1482–8.

PubMed  Google Scholar 

Tsukamura M. Diagnosis of disease caused by Mycobacterium avium complex. Chest. 1991;99(3):667–9.

CAS  PubMed  Google Scholar 

Ushiki A, Yamazaki Y, Koyama S, Tsushima K, Yamamoto H, Hanaoka M, et al. Bronchoscopic microsampling for bacterial colony counting in relevant lesions in patients with pulmonary Mycobacterium avium complex infection. Intern Med. 2011;50(12):1287–92.

PubMed  Google Scholar 

Sin S, Ha